Eaton Vance Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Eaton Vance Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-24,000	Closed	-$1.44M	–	1371
2019 Q4	$1.44M	Hold	24,000	–	–	﹤0.01%	897
2019 Q3	$674K	Hold	24,000	–	–	﹤0.01%	1059
2019 Q2	$909K	Hold	24,000	–	–	﹤0.01%	978
2019 Q1	$936K	Hold	24,000	–	–	﹤0.01%	929
2018 Q4	$512K	Buy	+24,000	New	+$619K	﹤0.01%	990

Eaton Vance Management's BOLD Position: Q1 2020 in Review

Eaton Vance Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 24,000 shares — an estimated $1.44M sold.

Eaton Vance Management first reported a position in BOLD in Q4 2018 and held it in 5 quarters. The position peaked at $1.44M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Eaton Vance Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Eaton Vance Management sold 24,000 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.44M.
Eaton Vance Management first reported a position in Audentes Therapeutics, Inc in Q4 2018 and held it in 5 quarters.
Eaton Vance Management's Audentes Therapeutics, Inc position peaked at $1.44M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Eaton Vance Management's 13F filing for Q1 2020, filed 14 May 2020.